BRTX BioRestorative Therapies, Inc. Common Stock (NV)
XNASStock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
BRTX
—
—
Key stats
About
- Industry (SIC)
- SERVICES-MISC HEALTH & ALLIED SERVICES, NEC (8090)
- Exchange
- XNAS
- Market Cap
- $0.0B
BioRestorative Therapies Inc is engaged in developing therapeutic products using cell and tissue protocols, involving adult stem cells. The company is pursuing its Disc/Spine Program with initial investigational therapeutic product being called BRTX-100 in the treatment of chronic cervical discogenic pain. The technology is an stem cell injection procedure that may offer relief from lower back pain, buttock and leg pain, and numbness and tingling in the leg and foot. It is also developing ThermoStem Program, a pre-clinical program which involves the use of brown adipose (fat) in connection wit…
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Chart
Seasonality
| Month | Avg Return | Years of Data |
|---|---|---|
| Jan | +7.13% | 5 |
| Feb | -16.16% | 5 |
| Mar | +13.37% | 5 |
| Apr | -3.09% | 5 |
| May | +23.43% | 5 |
| Jun | +1.16% | 5 |
| Jul | -21.99% | 5 |
| Aug | +1.59% | 5 |
| Sep | -16.30% | 5 |
| Oct | +2.05% | 5 |
| Nov | -12.74% | 5 |
| Dec | -11.58% | 5 |
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $2.54
SMA 50: $3.56
SMA 200: $8.35
Current: $2.28
EMA 12: $2.44
EMA 26: $2.86
MACD: -0.4215 | Signal: 0.0412
BEARISH
ADX (14): 41.08
STRONG TREND
+DI: 9.53
−DI: 28.17
Momentum Oscillators
RSI (14): 28.93
OVERSOLD
Stoch %K: 10.79
Stoch %D: 7.74
Williams %R: -70.58
Volume & Volatility
BB Upper: $2.92
BB Lower: $2.16
NEUTRAL
OBV: 42,933,614
Vol SMA 20: 32,604
Vol ROC: 181.77%
ATR: $0.27
True Range: $0.30
HV 20: 61.5%
HV 30: 110.9%
HV 60: 89.4%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-10-04T00:00:00 – 2026-10-02T00:00:00
AI Analysis
LLM Stock Analysis Report: BRTX
Executive Summary
Overall Assessment: BEARISH (Confidence Level: 6/10)
Key Drivers:
- Bearish technical indicators, including MACD and RSI
- High volatility and beta relative to the market
- Recent negative news sentiment and lack of earnings data
Primary Risks:
- Continued price decline due to bearish momentum
- Increased volatility and potential for sharp moves
Investment Thesis: BRTX is a high-risk stock with significant technical and fundamental challenges. While recent positive news headlines provide some support, the overall trend remains bearish. Investors should exercise caution and consider hedging strategies or reevaluating their investment position.
Recent News Sentiment Impact: The recent positive news sentiment has provided some support to the stock price, but the impact is limited given the bearish technical indicators and high volatility.
Technical Analysis
Trend Direction:
- Short-term: BEARISH
- Medium-term: BEARISH
- Long-term: NEUTRAL (trend unclear)
Support/Resistance Levels:
- Lower band: $2.83 (Bollinger Bands)
- Middle band: $3.98 (SMA 50)
- Upper band: $5.12 (Bollinger Bands)
Momentum Signals: RSI: 24.29 (oversold), MACD: -0.55 / Signal: -0.08 / Histogram: -0.47 (bearish), RSI momentum: -1.43
Volume Analysis: Volume SMA 20: 22660.56, On-Balance Volume (OBV): 42931204.17, Volume Rate of Change: 71.07%
News & Sentiment Analysis
Recent Headlines Summary:
- Positive news headlines highlighting company's advancements in regenerative spine program and bio-cosmeceuticals
- Neutral news headlines related to public offering and conference participation
- No negative news headlines found
Sentiment Assessment: Aggregate news sentiment: POSITIVE ( weighted average of positive headlines)
Catalyst Identification: No immediate or near-term catalysts identified, but the company's advancements in regenerative spine program could provide a medium-term catalyst.
Market Narrative: The positive news sentiment and company advancements are not sufficient to overcome the bearish technical indicators and high volatility. The market narrative remains neutral-to-bearish.
Risk & Volatility Assessment
Risk Interpretation: Beta: 1.64 (high-risk stock relative to the market)
Volatility Regime: High volatility - stock moves more than the market
Options Market Signals: IV rank: N/A, put/call ratios: N/A, unusual activity: N/A
Downside Protection: Support levels: $2.83 (Bollinger Bands), risk management considerations: stop-loss at $3.00
Market Context & Positioning
Sector Performance: Relative strength vs sector/market: NEUTRAL
Institutional Activity: Volume patterns suggesting institutional interest: MIXED
Correlation Analysis: How stock moves relative to market (R-squared interpretation): 0.15 (high correlation)
Relative Valuation: Position within trading range: BEARISH (stock below its middle band)
Key Levels & Action Items
Critical Price Levels:
- Support: $2.83 (Bollinger Bands)
- Resistance: $3.98 (SMA 50)
Breakout/Breakdown Levels: None identified
Time-Sensitive Catalysts: No immediate or near-term catalysts identified, but the company's advancements in regenerative spine program could provide a medium-term catalyst.
Risk Management: Stop-loss at $3.00, position sizing considerations: reduce exposure or consider hedging strategies
Generated
News
BRTX Options Activity & IV Rank
Loading options activity...
Spread Scanner GPU
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score (GPU scanner)
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
—
—
pts
EXTREME
ATM — / Wing —
30 DTE / 10d
—
—
pts
EXTREME
ATM — / Wing —
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Enter a ticker to render the implied volatility surface.
Volatility Smile
Enter a ticker to render the implied volatility smile.
IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
- Beta (1Y vs SPY)
- 1.64
- Correlation (SPY)
- 14.8%
- R²
- 0.02
- Ann. Volatility
- 144.2%
- SPY Volatility
- 13.0%
High volatility - stock moves more than market
Beta & Alpha Over Time
BRTX Institutional Ownership (13F)
Latest filings — 2026-06-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|
| # | Filer | Notional Value | % of Total | Period |
|---|
BRTX Insider Trading (Form 4)
Latest: 2025-10-20Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2025-10-20 | Lance Alstodt | President, CEO, COB | Award (A) | +15,625 | $1.60 | $25.0K | EDGAR |
| 2025-10-20 | Francisco Silva | VP of Research and Development | Award (A) | +11,719 | $1.60 | $18.8K | EDGAR |
| 2025-02-19 | David A Rosa | Director | Grant (A) | +52,632 opt | — | EDGAR | |
| 2025-02-19 | Lance Alstodt | President, CEO, COB | Award (A) | — | — | EDGAR | |
| 2025-02-19 | Nickolay V. Kukekov | Director | Grant (A) | +52,632 opt | — | EDGAR | |
| 2025-02-19 | Robert Eugene Kristal | Chief Financial Officer | Award (A) | — | — | EDGAR | |
| 2025-02-19 | Patrick F. Williams | Director | Grant (A) | +52,632 opt | — | EDGAR | |
| 2025-02-19 | Francisco Silva | VP of Research and Development | Award (A) | — | — | EDGAR | |
| 2024-11-05 | Dale Broadrick | 10%+ Owner | Sell (S) | −1,112 | $1.58 | -$1.8K | EDGAR |
| 2024-04-10 | Francisco Silva | VP of Research and Development | Buy (P) | +8,308 | $1.23 | $10.2K | EDGAR |
| 2024-03-20 | Lance Alstodt | President, CEO, COB | Tax (F) | −17,633 | $1.39 | -$24.5K | EDGAR |
| 2024-03-20 | Francisco Silva | VP of Research and Development | Tax (F) | −17,193 | $1.39 | -$23.9K | EDGAR |
| 2024-02-15 | Nickolay V. Kukekov | Director | Grant (A) | +79,646 opt | — | EDGAR | |
| 2024-02-15 | Robert Paccasassi | VP, QA and Reg Compliance | Grant (A) | +219,298 opt | — | EDGAR | |
| 2024-02-15 | Robert Eugene Kristal | Chief Financial Officer | Award (A) | — | — | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
BRTX Insider Holdings
4 insiders · @ $2.28
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Dale Broadrick | 10%+ Owner | 46,196 | $105.3K | $1.75M | 26 | 2024-11-05 |
| 2 | Lance Alstodt | President, CEO, COB | 9,375 | $21.4K | $124.9K | 39 | 2025-10-20 |
| 3 | Francisco Silva | VP of Research and Development | 9,176 | $20.9K | $116.4K | 21 | 2025-10-20 |
| 4 | Robert Eugene Kristal | Chief Financial Officer | 400 | $912 | $45.0K | 8 | 2025-02-19 |
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
ETF Holders
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.